Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09IUR
|
|||
| Former ID |
DIB015483
|
|||
| Drug Name |
Midismase
|
|||
| Synonyms |
PC-01; SI-3501; PC-SOD (intravenous), LTT; Lecithin-bound superoxide dismutase (ulcerative colitis), LTT Bio-Pharma
Click to Show/Hide
|
|||
| Indication | Cerebral infarction [ICD-11: 8B11.5Z; ICD-10: I63] | Phase 2 | [1] | |
| Company |
Asahi Glass Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Superoxide dismutase Cu-Zn (SOD Cu-Zn) | Target Info | Modulator | [2] |
| BioCyc | Reactive oxygen species degradation | |||
| KEGG Pathway | Peroxisome | |||
| Amyotrophic lateral sclerosis (ALS) | ||||
| Huntington's disease | ||||
| Prion diseases | ||||
| NetPath Pathway | TCR Signaling Pathway | |||
| Pathwhiz Pathway | Degradation of Superoxides | |||
| Pathway Interaction Database | Validated nuclear estrogen receptor alpha network | |||
| FOXA1 transcription factor network | ||||
| Reactome | Platelet degranulation | |||
| Detoxification of Reactive Oxygen Species | ||||
| WikiPathways | Oxidative Stress | |||
| Copper homeostasis | ||||
| Detoxification of Reactive Oxygen Species | ||||
| Nifedipine Activity | ||||
| Amyotrophic lateral sclerosis (ALS) | ||||
| Dopamine metabolism | ||||
| AGE/RAGE pathway | ||||
| Folate Metabolism | ||||
| Vitamin B12 Metabolism | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00685763) Proton Therapy for Unresectable Cancer (CA) of Pancreas. U.S. National Institutes of Health. | |||
| REF 2 | A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.